News
thumbnail
Deal-MakingSK pharmteco secures $1.4bn GLP-1 dealSK pharmteco secures $1.4bn GLP-1 deal
In addition to producing glucagon-like peptide-1 (GLP-1) drugs for an anonymous partner over five years, the Korean firm is consolidating its brands.